Career history of Oren Isacoff
Former positions of Oren Isacoff
| Companies | Position | Start | End |
|---|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director/Board Member | 2018-12-31 | 2022-05-30 |
TPG Special Situations Partners LLC
 TPG Special Situations Partners LLC Finance/Rental/LeasingFinance TPG Special Situations Partners LLC provides financial services. The company is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 2014-08-31 | 2015-04-30 |
Training of Oren Isacoff
| The Wharton School of the University of Pennsylvania | Graduate Degree |
| University of Pennsylvania | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
TPG Special Situations Partners LLC
TPG Special Situations Partners LLC Finance/Rental/LeasingFinance TPG Special Situations Partners LLC provides financial services. The company is headquartered in Fort Worth, TX. | Finance |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Oren Isacoff
- Experience
